
|Articles|September 3, 2007
New HIV drug first to target CCR5 receptor
A drug with a new mechanism of action is always a welcome addition in the fight against HIV. Maraviroc was recently approved by the FDA and is the first of the chemokine receptor 5 antagonists to enter the market.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
CVS Pharmacy Acquires Select Rite Aid Assets in 3 States, Accounting for Over 600 Stores
2
FDA Approves Afibercept-Boav as Biosimilar to Afibercept for Diabetic Macular Edema
3
Vaccination of 3 Or More Doses Reduces Incidence of COVID-19 Symptoms for Young Adults
4
FDA Approves Risperidone Injection for Bipolar I Disorder in Adults
5